Aimei Health Terminates Planned Business Combination Agreement

Aimei Health Technology Co., Ltd ( (AFJK) ) has issued an announcement.

On July 7, 2026, Aimei Health Technology Co., Ltd. delivered a notice terminating its Business Combination Agreement, originally signed on June 19, 2024 and amended on June 6, 2025, with United Hydrogen Group Inc. and related Cayman Islands entities after the transaction failed to close by the contractual outside date. The company announced the termination publicly on July 8, 2026, signaling the collapse of the planned merger and a renewed search for an alternative target, which may affect deal expectations for investors but leaves Aimei Health pursuing other potential transactions in line with its acquisition-focused mandate.

Chief Executive Officer and Director Xie Junheng acknowledged that the parties were unable to complete the combination within the required timeframe but emphasized confidence in Aimei Health’s ability to identify and execute a compelling transaction going forward. While the decision ends the proposed tie-up with United Hydrogen, the company’s stated intent to continue pursuing a new deal suggests its capital and listing vehicle remain in play for future mergers, with implications for both its own shareholders and potential counterparties.